BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26467274)

  • 1. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
    Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The time-dependent accumulation of protoporphyrin IX fluorescence in nodular basal cell carcinoma following application of methyl aminolevulinate with an oxygen pressure injection device.
    Blake E; Campbell S; Allen J; Mathew J; Helliwell P; Curnow A
    J Photochem Photobiol B; 2012 Dec; 117():97-103. PubMed ID: 23092624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.
    Blake E; Allen J; Thorn C; Shore A; Curnow A
    Lasers Med Sci; 2013 May; 28(3):997-1005. PubMed ID: 22926533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells.
    Smits T; van Laarhoven AI; Staassen A; van de Kerkhof PC; van Erp PE; Gerritsen MJ
    Br J Dermatol; 2009 Apr; 160(4):849-57. PubMed ID: 19175603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
    Tyrrell J; Campbell S; Curnow A
    Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):86-97. PubMed ID: 20510303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
    Mikolajewska P; Iani V; Juzeniene A; Moan J
    Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
    Nissen CV; Philipsen PA; Wulf HC
    Br J Dermatol; 2015 Sep; 173(3):760-6. PubMed ID: 25997508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the thin layer of methyl aminolevulinate used during photodynamic therapy sufficient?
    Wiegell SR; Lerche CM; Wulf HC
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):88-92. PubMed ID: 26577455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
    Tyrrell JS; Morton C; Campbell SM; Curnow A
    Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
    Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
    Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
    Heerfordt IM; Bieliauskiene G; Wulf HC
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative study of in vivo protoporphyrin IX fluorescence build up during occlusive treatment phases.
    Campbell CL; Brown CTA; Wood K; Salvio AG; Inada NM; Bagnato VS; Moseley H
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():204-207. PubMed ID: 28257944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
    Nissen CV; Heerfordt IM; Wiegell SR; Mikkelsen CS; Wulf HC
    Br J Dermatol; 2017 May; 176(5):1241-1246. PubMed ID: 27696393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
    Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
    Lesar A; Ferguson J; Moseley H
    Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
    Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
    Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
    Choudry K; Brooke RC; Farrar W; Rhodes LE
    Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
    de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
    J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
    Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
    J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.